RxDoctor Payments Data

Karla Berrios Sierra, MD

Family Medicine · San Juan, PRNPI 1558590059

Payments from drug & device makers

$648in general payments, 2019–2025

Across 16 payments — averaging $40.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$237
  • E.r. Squibb & Sons, L.L.C.$170
  • PBG Puerto Rico LLC$81
  • AbbVie$73
  • Boehringer Ingelheim$26
  • Biocryst US Sales Co., LLC$23
  • plus $38 from 2 others

What the payments were for

  • Food & beverage$648100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Lilly USA, LLC2$237
E.r. Squibb & Sons, L.L.C.3$170
PBG Puerto Rico LLC4$81
AbbVie3$73
Boehringer Ingelheim1$26
Biocryst US Sales Co., LLC1$23
Sanofi-aventis U.S. LLC1$23
Pfizer Pharmaceuticals LLC1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$648 in reported general payments places this provider in the 70th percentile of 497 family medicine providers in Puerto Rico.

See all family medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$3,365
Medicare patients
11
Services billed
43

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TradjentaLinagliptin77$48,774
EliquisApixaban53$33,890
JardianceEmpagliflozin36$23,671
XareltoRivaroxaban33$19,067
SynthroidLevothyroxine Sodium261$14,541
JentaduetoLinagliptin/Metformin Hcl21$11,164
Synjardy XrEmpagliflozin/Metformin Hcl14$8,649
JanuviaSitagliptin Phosphate15$8,519
FarxigaDapagliflozin Propanediol13$7,489
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,705
BrilintaTicagrelor11$5,009
LantusInsulin Glargine,hum.Rec.Anlog62$4,337
Losartan Potassium589$4,257
Fluticasone Propionate HfaFluticasone Propionate19$3,878
HumalogInsulin Lispro26$3,799

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimTradjenta, Jardiance, Jentadueto, Synjardy Xr$26$92,258148 claims
AbbVieSynthroid$73$14,541261 claims
Lilly USA, LLCHumalog, Humulin N$237$6,02646 claims
Sanofi-aventis U.S. LLCLantus$23$4,33762 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 497 family medicine providers in Puerto Rico.

Other family medicine in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →